Cano Health Files Amendment for MSP Recovery Stake

TL;DR

Cano Health updated its filing on MSP Recovery stake - watch for changes.

AI Summary

On March 5, 2024, Cano Health, Inc. filed an SC 13D/A amendment regarding its holdings in MSP Recovery, Inc. This filing is an amendment to a previous filing, indicating changes in Cano Health's stake or intentions concerning MSP Recovery, Inc. The filing does not disclose specific dollar amounts or new share counts in this amendment.

Why It Matters

This filing signals a potential shift in the relationship or investment strategy between Cano Health and MSP Recovery, Inc., which could impact both companies' stock performance.

Risk Assessment

Risk Level: medium — Amendments to Schedule 13D filings often indicate changes in a significant shareholder's intentions or holdings, which can introduce volatility.

Key Players & Entities

• Cano Health, Inc. (company) — Filing entity
• MSP Recovery, Inc. (company) — Subject company
• Lionheart Acquisition Corp. II (company) — Former company name of MSP Recovery, Inc.
• Lionheart Acquisition Corp. (company) — Former company name of MSP Recovery, Inc.
• Jaws Acquisition Corp. (company) — Former company name of Cano Health, Inc.

FAQ

Key Financial Figures

• $0.0001 — suer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• d740451dsc13da.htm (SC 13D/A) — 34KB
• 0001193125-24-059492.txt ( ) — 36KB

From the Filing

SC 13D/A 1 d740451dsc13da.htm SC 13D/A SC 13D/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 8)* MSP Recovery, Inc. (Name of Issuer) Class A Common Stock, par value $0.0001 per share (Title of Class of Securities) 553745100 (CUSIP Number) David J. Armstrong, Esq. General Counsel Cano Health, Inc. 9725 NW 117th Avenue Miami, Florida 33178 Tel: (855) 226-6633 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) March 1, 2024 (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box: Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 ( Act ) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No.: 553745100 1 NAMES OF REPORTING PERSONS Cano Health, Inc. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a)(b) 3 SEC USE ONLY 4 SOURCE OF FUNDS OO 5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) 6 CITIZENSHIP OR PLACE OF ORGANIZATION Delaware NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 7 SOLE VOTING POWER 2,977,913 8 SHARED VOTING POWER 0 9 SOLE DISPOSITIVE POWER 2,977,913 10 SHARED DISPOSITIVE POWER 0 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,977,913 12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 20.1%(1) 14 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (1) The 2,977,913 shares of Class A common stock of MSP Recovery, Inc. (the Issuer) reported herein represents 2.1% of the Issuers total issued and outstanding voting shares. (See Item 5 of the Schedule 13D.) 2 This Amendment No. 8 ( Amendment No. 8 ) to Schedule 13D relates to the Class A Common Stock, par value $0.0001 per share (the Class A Shares ), of MSP Recovery, Inc., a Delaware corporation (the Issuer ), and amends and supplements the initial statement on Schedule 13D filed by Cano Health, Inc., a Delaware corporation (the Reporting Person ), with the Securities and Exchange Commission ( SEC ) on July 17, 2023, as amended by Amendment No. 1 to the Schedule 13D filed with the SEC on January 12, 2024, as amended by Amendment No. 2 to the Schedule 13D filed with the SEC on January 24, 2024, as amended by Amendment No. 3 to the Schedule 13D filed with the SEC on January 31, 2024, as amended by Amendment No. 4 to the Schedule 13D filed with the SEC on February 6, 2024, as amended by Amendment No. 5 to the Schedule 13D filed with the SEC on February 12, 2024, as amended by Amendment No. 6 to the Schedule 13D filed with the SEC on February 16, 2024, as amended by Amendment No. 7 to the Schedule 13D filed with the SEC on February 26, 2024 (as so amended, the Schedule 13D ). Capitalized terms used but not defined in this Amendment No. 8 shall have the same meanings ascribed to them in the Schedule 13D. Item5. Interest in Securities of the Issuer. Items 5(a)-(c) of the Schedule 13D are hereby amended and restated as follows: (a) and (b) The percentage of beneficial ownership of the Class A Shares reported in this Schedule 13D assumes 14,803,125 Class A Shares outstanding as of February 2, 2024, based on information set forth in the Form S-1/A filed by the Issuer on February 9, 2024 (the Form S-1/A ). As of March 5, 2024, the aggregate number and percentage of Class A Shares beneficially owned by the Reporting Person and, for the Reporting Person, the number of shares as to which there is sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition, or shared power to dispose or to direct the disposition are set forth on rows 7 through 11 and row 13 of the cover page of this Schedule 13D and are incorporated herein by reference. As of March 5, 2024, Cano Health, LLC, an indirect subsidiary of the Reporting Person, directly owns the 2,977,913 Class A Shares repor

View Full Filing

View this SC 13D/A filing on SEC EDGAR